Detalhe da pesquisa
1.
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients.
Int J Gynecol Cancer
; 33(2): 257-262, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581488
2.
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade.
Clin Transl Med
; 14(5): e1655, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711203